Lessons learnt from Genasense's failure.
Simon
S
Frantz
D017277:Drug Approval; D023381:Endpoint Determination; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis; D013873:Thionucleotides / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D013873:Thionucleotides; C408162:oblimersen